Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 
Diseases » Hyperglycemia » Glossary
 

Glossary for Hyperglycemia

  • ACTH -- Teratogenic Agent: Experimental studies on mice indicate that the use of ACTH during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Abdominal obesity metabolic syndrome: A syndrome characterized by a group of conditions that are considered major risk factors for diabetes mellitus and cardiovascular disease.
  • Acquired total lipodystrophy: A rare acquired disorder that involves adipose tissue abnormalities and is characterized by loss of adipose tissue through the body. The disorder is very similar to the congenital form but the liver involvement is more severe.
  • Acromegaly: A hormonal disorder involving excess growth hormone production by the pituitary gland.
  • Acute Pancreatitis: Sudden severe inflammation of the pancreas causing digestive complaints.
  • Adrenal Cortex Diseases: Diseases of the adrenal cortex. Examples includes Addison's disease, Cushing's syndrome and adrenal fatigue.
  • Aminophyllin -- Teratogenic Agent: Experimental studies on rats indicate that the use of Aminophyllin during pregnancy may cause various harmful effects on the fetus. The likelihood and severity of symptoms may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at. The effect on human fetuses has not been conclusively determined.
  • Amlodipine toxicity: The toxic reaction of the body to the substance, possibly via allergic reaction or overdose.
  • Anophthalmia -- short stature -- obesity: A very rare syndrome characterized by absent eyes, short stature and obesity.
  • Arizona Bark Scorpion poisoning: A bite from the Arizona Bark scorpion contains chemicals toxic to the nerve system and can cause serious, life-threatening symptoms.
  • Bard-Pic syndrome: The presence of jaundice, enlarged gallbladder and progressive wasting of the body which indicates a head or pancreatic cancer.
  • Blood conditions: Conditions that affect the blood
  • Brunzell syndrome: A rare recessively inherited syndrome characterized by a lack of skin fat (Seip syndrome), cystic angiomatosis of the long bones which can lead to fractures.
  • Bumetanide -- Teratogenic Agent: There is strong evidence to indicate that exposure to Bumetanide during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cephalothoracic progressive lipodystrophy: A rare acquired disorder that involves adipose tissue abnormalities and is characterized by loss of adipose tissue mainly in the trunk and arms.
  • Chemical poisoning -- 1,3-Dichloropropene: 1,3-Dichloropropene is a chemical used in solvents and soil fumigants for nematode control. The type and severity of symptoms varies depending on the amount of chemical involved and the nature of the exposure.
  • Christian-Demyer-Franken syndrome: A rare syndrome characterized mainly by mental retardation and skeletal abnormalities.
  • Chronic Pancreatitis: Chronic ongoing inflammation of the pancreas causing digestive complaints.
  • Cirrhosis of the liver: Scarring of the liver from alcohol or other causes.
  • Congenital partial lipodystrophy: A rare congenital disorder that involves adipose tissue abnormalities and is characterized by loss of adipose tissue mainly in the trunk and limbs.
  • Corticotropin -- Teratogenic Agent: There is evidence to indicate that exposure to Corticotropin during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Cushing syndrome, familial: A hormonal disorder caused by high levels of the cortisol hormone due to the abnormal development of the adrenal gland.
  • Cushing's disease: A condition of hyperadrenocorticism which is secondary to excessive pituitary secretion of ACTH. Cushing's disease is different to Cushing's syndrome which refers to the effects of glucocorticoid excess from any cause.
  • Cushing's syndrome: A rare syndrome where excessive secretion of corticosteroids by the adrenal cortex leads to a variety of symptoms. Hormone-secreting adrenal or pituitary tumors are often the cause of the excessive corticosteroid secretion.
  • Cystic Fibrosis: Cystic fibrosis is a hereditary disease affecting the exocrine (mucus) glands of the lungs, liver, pancreas, and intestines, causing progressive disability due to multisystem failure.
  • DEND syndrome: An inherited disorder characterized by developmental delay, epilepsy and diabetes.
  • Dehydration: Loss of fluids in the body
  • Delta-1-pyrroline-5-carboxylate dehydrogenase deficiency: A rare metabolic abnormality involving a deficiency of a particular enzyme (Delta-1-pyrroline-5-carboxylate dehydrogenase) which affects amino acid metabolism and causes mental retardation and convulsions.
  • Diabetes: Failing or reduced ability of the body to handle sugars.
  • Diabetes Mellitus, Insulin-Dependent, Susceptibility to, 1: Insulin-dependent diabetes is a condition where the body is unable to produce its own insulin in sufficient quantities to regulate blood sugar levels. Researchers have discovered a number of genes which are linked to an increased risk of developing type 1 diabetes. The genetic anomaly alone is not enough to cause the disease but simply increases the risk. Type 1 is linked to a defect on chromosome 6p21.
  • Diabetes Mellitus, Insulin-Dependent, Susceptibility to, 10: Insulin-dependent diabetes is a condition where the body is unable to produce its own insulin in sufficient quantities to regulate blood sugar levels. Researchers have discovered a number of genes which are linked to an increased risk of developing type 1 diabetes. The genetic anomaly alone is not enough to cause the disease but simply increases the risk. Type 10 is linked to a defect on chromosome 10p15.1.
  • Diabetes Mellitus, Insulin-Dependent, Susceptibility to, 11: Insulin-dependent diabetes is a condition where the body is unable to produce its own insulin in sufficient quantities to regulate blood sugar levels. Researchers have discovered a number of genes which are linked to an increased risk of developing type 1 diabetes. The genetic anomaly alone is not enough to cause the disease but simply increases the risk. Type 11 is linked to a defect on chromosome 14q24.3-q31.
  • Diabetes Mellitus, Insulin-Dependent, Susceptibility to, 12: Insulin-dependent diabetes is a condition where the body is unable to produce its own insulin in sufficient quantities to regulate blood sugar levels. Researchers have discovered a number of genes which are linked to an increased risk of developing type 1 diabetes. The genetic anomaly alone is not enough to cause the disease but simply increases the risk. Type 12 is linked to a defect on chromosome 2q33.
  • Diabetes Mellitus, Insulin-Dependent, Susceptibility to, 13: Insulin-dependent diabetes is a condition where the body is unable to produce its own insulin in sufficient quantities to regulate blood sugar levels. Researchers have discovered a number of genes which are linked to an increased risk of developing type 1 diabetes. The genetic anomaly alone is not enough to cause the disease but simply increases the risk. Type 13 is linked to a defect on chromosome 2q34.
  • Diabetes Mellitus, Insulin-Dependent, Susceptibility to, 15: Insulin-dependent diabetes is a condition where the body is unable to produce its own insulin in sufficient quantities to regulate blood sugar levels. Researchers have discovered a number of genes which are linked to an increased risk of developing type 1 diabetes. The genetic anomaly alone is not enough to cause the disease but simply increases the risk. Type 15 is linked to a defect on chromosome 6q21.
  • Diabetes Mellitus, Insulin-Dependent, Susceptibility to, 17: Insulin-dependent diabetes is a condition where the body is unable to produce its own insulin in sufficient quantities to regulate blood sugar levels. Researchers have discovered a number of genes which are linked to an increased risk of developing type 1 diabetes. The genetic anomaly alone is not enough to cause the disease but simply increases the risk. Type 17 is linked to a defect on chromosome 10q25.
  • Diabetes Mellitus, Insulin-Dependent, Susceptibility to, 18: Insulin-dependent diabetes is a condition where the body is unable to produce its own insulin in sufficient quantities to regulate blood sugar levels. Researchers have discovered a number of genes which are linked to an increased risk of developing type 1 diabetes. The genetic anomaly alone is not enough to cause the disease but simply increases the risk. Type 18 is linked to a defect on chromosome 5q31.1-q33.1.
  • Diabetes Mellitus, Insulin-Dependent, Susceptibility to, 19: Insulin-dependent diabetes is a condition where the body is unable to produce its own insulin in sufficient quantities to regulate blood sugar levels. Researchers have discovered a number of genes which are linked to an increased risk of developing type 1 diabetes. The genetic anomaly alone is not enough to cause the disease but simply increases the risk. Type 19 is linked to a defect on chromosome 2q24.3.
  • Diabetes Mellitus, Insulin-Dependent, Susceptibility to, 2: Insulin-dependent diabetes is a condition where the body is unable to produce its own insulin in sufficient quantities to regulate blood sugar levels. Researchers have discovered a number of genes which are linked to an increased risk of developing type 1 diabetes. The genetic anomaly alone is not enough to cause the disease but simply increases the risk. Type 2 is linked to a defect on chromosome 11p15.5.
  • Diabetes Mellitus, Insulin-Dependent, Susceptibility to, 20: Insulin-dependent diabetes is a condition where the body is unable to produce its own insulin in sufficient quantities to regulate blood sugar levels. Researchers have discovered a number of genes which are linked to an increased risk of developing type 1 diabetes. The genetic anomaly alone is not enough to cause the disease but simply increases the risk. Type 20 is linked to a defect on chromosome 12q24.
  • Diabetes Mellitus, Insulin-Dependent, Susceptibility to, 21: Insulin-dependent diabetes is a condition where the body is unable to produce its own insulin in sufficient quantities to regulate blood sugar levels. Researchers have discovered a number of genes which are linked to an increased risk of developing type 1 diabetes. The genetic anomaly alone is not enough to cause the disease but simply increases the risk. Type 21 is linked to a defect on chromosome 6q25.
  • Diabetes Mellitus, Insulin-Dependent, Susceptibility to, 22: Insulin-dependent diabetes is a condition where the body is unable to produce its own insulin in sufficient quantities to regulate blood sugar levels. Researchers have discovered a number of genes which are linked to an increased risk of developing type 1 diabetes. The genetic anomaly alone is not enough to cause the disease but simply increases the risk. Type 22 is linked to a defect on chromosome 3p21.
  • Diabetes Mellitus, Insulin-Dependent, Susceptibility to, 23: Insulin-dependent diabetes is a condition where the body is unable to produce its own insulin in sufficient quantities to regulate blood sugar levels. Researchers have discovered a number of genes which are linked to an increased risk of developing type 1 diabetes. The genetic anomaly alone is not enough to cause the disease but simply increases the risk. Type 23 is linked to a defect on chromosome 4q27.
  • Diabetes Mellitus, Insulin-Dependent, Susceptibility to, 24: Insulin-dependent diabetes is a condition where the body is unable to produce its own insulin in sufficient quantities to regulate blood sugar levels. Researchers have discovered a number of genes which are linked to an increased risk of developing type 1 diabetes. The genetic anomaly alone is not enough to cause the disease but simply increases the risk. Type 24 is linked to a defect on chromosome 10q23.31.
  • Diabetes Mellitus, Insulin-Dependent, Susceptibility to, 3: Insulin-dependent diabetes is a condition where the body is unable to produce its own insulin in sufficient quantities to regulate blood sugar levels. Researchers have discovered a number of genes which are linked to an increased risk of developing type 1 diabetes. The genetic anomaly alone is not enough to cause the disease but simply increases the risk. Type 3 is linked to a defect on chromosome 15q26.
  • Diabetes Mellitus, Insulin-Dependent, Susceptibility to, 4: Insulin-dependent diabetes is a condition where the body is unable to produce its own insulin in sufficient quantities to regulate blood sugar levels. Researchers have discovered a number of genes which are linked to an increased risk of developing type 1 diabetes. The genetic anomaly alone is not enough to cause the disease but simply increases the risk. Type 4 is linked to a defect on chromosome 11q13.
  • Diabetes Mellitus, Insulin-Dependent, Susceptibility to, 5: Insulin-dependent diabetes is a condition where the body is unable to produce its own insulin in sufficient quantities to regulate blood sugar levels. Researchers have discovered a number of genes which are linked to an increased risk of developing type 1 diabetes. The genetic anomaly alone is not enough to cause the disease but simply increases the risk. Type 5 is linked to a defect on chromosome 6q25.
  • Diabetes Mellitus, Insulin-Dependent, Susceptibility to, 6: Insulin-dependent diabetes is a condition where the body is unable to produce its own insulin in sufficient quantities to regulate blood sugar levels. Researchers have discovered a number of genes which are linked to an increased risk of developing type 1 diabetes. The genetic anomaly alone is not enough to cause the disease but simply increases the risk. Type 6 is linked to a defect on chromosome 18q21.
  • Diabetes Mellitus, Insulin-Dependent, Susceptibility to, 7: Insulin-dependent diabetes is a condition where the body is unable to produce its own insulin in sufficient quantities to regulate blood sugar levels. Researchers have discovered a number of genes which are linked to an increased risk of developing type 1 diabetes. The genetic anomaly alone is not enough to cause the disease but simply increases the risk. Type 7 is linked to a defect on chromosome 2q31.
  • Diabetes Mellitus, Insulin-Dependent, Susceptibility to, 8: Insulin-dependent diabetes is a condition where the body is unable to produce its own insulin in sufficient quantities to regulate blood sugar levels. Researchers have discovered a number of genes which are linked to an increased risk of developing type 1 diabetes. The genetic anomaly alone is not enough to cause the disease but simply increases the risk. Type 81 is linked to a defect on chromosome 6q25-q27.
  • Diabetes mellitus, permanent neonatal -- pancreatic and cerebellar agenesis: A rare syndrome characterized by the abnormal development of the cerebellum and pancreas which results in diabetes mellitus.
  • Diabetes mellitus, transient neonatal: A form of infant diabetes that starts usually in the month of life but then usually disappears within a year. The condition predisposes the infant to diabetes later in life.
  • Diabetic Ketoacidosis: Life-threatening complication of high blood sugars and diabetes.
  • Dilantin -- Teratogenic Agent: There is strong evidence to indicate that the use of Dilantin (anti-seizure medication) during pregnancy may cause a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Dilor -- Teratogenic Agent: There is evidence to indicate that exposure to Dilor (a bronchodilator) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Dyphylline -- Teratogenic Agent: There is evidence to indicate that exposure to Dyphylline (a bronchodilator) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Fanconi-Bickel syndrome: A rare inherited disorder where the impaired metabolism of carbohydrates results in a build-up of glycogen in the liver.
  • Felodipine toxicity: The toxic reaction of the body to the substance, possibly via allergic reaction or overdose.
  • Friedreich ataxia: A progressive inherited neuromuscular disorder involving slow degeneration of the spinal cord and brain.
  • Functioning pancreatic endocrine tumor: Tumors that develop in the pancreas and cause excessive secretion of one or more pancreatic hormones such as insulin, somatostatin, glucagons, gastrin, ACTH (corticosteroids) and vasoactive intestinal peptidase.
  • Gestational diabetes: Diabetes that occurs in pregnant women, usually resolving after birth.
  • Glucagonoma: Rare cancer of the glucagon-producing pancreas cells.
  • Glucagonoma syndrome: A rare condition characterized by a tumor which secretes glucagon and a characteristic spreading rash, diabetes mellitus and various other symptoms.
  • Hereditary Hemochromatosis: A genetic disorder where too much iron is absorbed from food and it is stored in various parts of the body which can cause damage. There are 4 types of hemochromatosis and they are distinguished by age of onset, genetic cause and type of inheritance. Some sufferers may be asymptomatic.
  • Hydrochlorothiazide -- Teratogenic Agent: There is evidence to indicate that exposure to Hydrochlorothiazide during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Hyperglycemia: High levels of glucose in the blood
  • Hyperglycemic Hyperosmolar Nonketotic Syndrome: Life-threatening complication of high blood sugars and diabetes.
  • Hyperosmolar hyperglycemic nonketotic syndrome: A form of diabetic coma seen in type 2 diabetes mellitus
  • Hyperprolinemia type 2: A rare metabolic abnormality involving a deficiency of a particular enzyme (Delta-1-pyrroline-5-carboxylate dehydrogenase) which affects amino acid metabolism and causes mental retardation and convulsions.
  • Hypokalemia: Low levels of potassium in the body.
  • Hyponatraemia: Hyponatraemia means there is a lower than normal concentration of sodium in the blood.
  • Ichthyosis and male hypogonadism: A very rare syndrome characterized mainly by scaly skin and insufficient hormone production by the male gonads.
  • Ichthyosis male hypogonadism: A very rare syndrome characterized mainly by scaly skin and insufficient hormone production by the male gonads.
  • Impaired glucose tolerance: Mild glucose metabolism problems not severe enough to be called diabetes.
  • Indomethacin -- Teratogenic Agent: There is evidence to indicate that exposure to Indomethacin during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Insulin-resistance syndrome, type A: A syndrome characterized by insulin resistance resulting in distinctive skin lesions called acanthosis nigricans. It is the least severe form of insulin resistance.
  • Insulin-resistance type B: A very rare syndrome where insulin resistance is associated with autoimmune disease. The disorder is caused by antibodies which attack the bodies insulin receptors.
  • Isoniazid -- Teratogenic Agent: There is evidence to indicate that exposure to Isoniazid during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Isoniazid toxicity: The toxic reaction of the body to the substance, possibly via allergic reaction or overdose.
  • Isradipine toxicity: The toxic reaction of the body to the substance, possibly via allergic reaction or overdose.
  • Leprechaunism: A very rare genetic disorder characterized by insulin resistance which leads to growth delay and endocrine system abnormalities.
  • Leschke syndrome: A condition involving weakness, high blood sugar and brown skin spots which may be the early symptoms of conditions such as bronze diabetes or xanthoma diabeticorum.
  • Lipoatrophic diabetes:
  • Lipodystrophy, familial partial, type 1 (FPLD1): An inherited disorder characterized by the loss of fatty tissue from the extremities while fatty tissue on the face, neck and trunk is normal or increased.
  • Lipodystrophy, familial partial, type 3 (FPLD3): A rare metabolic disorder involving abnormal fat gradually disappears from the limbs, trunk and buttocks but stays the same or accumulates on areas such as the face, shoulders, neck and genitals.
  • Lufyllin -- Teratogenic Agent: There is evidence to indicate that exposure to Lufyllin (a bronchodilator) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • MELAS: A mitochondrial disorder characterized by stroke-like episodes, headaches, vomiting and other neurological symptoms.
  • MODY diabetes: Maturity Onset Diabetes of the Young affects approximately one or two per cent of people who have diabetes, and may often go unrecognised in its early stages. It is a form of diabetes that develops before the patient reaches 25. It also runs in families, and can pass from one generation to the next. MODY does not always require insulin treatment.
  • MODY syndrome: A dominantly inherited form of type II diabetes that occurs in young people (less than 25 years old) and is not insulin-dependent. The diabetes results due to genetic mutations which leads to dysfunctional insulin-producing pancreatic cells. There are 6 different genetic mutations that can cause this type of diabetes.
  • MODY syndrome, type 1: A dominantly inherited form of type II diabetes that occurs in young people (less than 25 years old) and is not insulin-dependent. MODY type 1 is due to a mutation of the HNF4A gene on chromosome 20.
  • MODY syndrome, type III: A dominantly inherited form of type II diabetes that occurs in young people (less than 25 years old) and is not insulin-dependent. MODY type 3 is due to a mutation of the hepatic transcriptor factor-1 gene on chromosome 12q24.2. The hyperglycemia in this form of the condition tends to increase with time and hence eventually requires treatment in the form of medication in many patients.
  • MODY syndrome, type IV: A dominantly inherited form of type II diabetes that occurs in young people (less than 25 years old) and is not insulin-dependent. MODY type 4 is due to a mutation of the insulin promoter factor-1 gene on chromosome 13q12.1.
  • Maternally inherited diabetes and deafness: A rare disorder characterized by deafness associated with noninsulin-dependent diabetes mellitus.
  • Metabolic Syndrome: A common body syndrome with the "deadly quartet" of major conditions: obesity, diabetes, hypertension, and high lipids.
  • Metabolic disorders: Disorders that affect the metabolic system in human
  • Myotonic Dystrophy: An inherited disorder characterized by progressive muscle weakness and wasting as well as eye defects, heart abnormalities and other anomalies. The severity of the condition is greatly variable. There are two type of myotonic dystrophy with type 1 being more severe than type 2.
  • Niacin overdose: Excessive vitamin B3 (niacin) supplement or medication
  • Nifedipine toxicity: The toxic reaction of the body to the substance, possibly via allergic reaction or overdose.
  • Nimodipine toxicity: The toxic reaction of the body to the substance, possibly via allergic reaction or overdose.
  • Olanzapine -- Teratogenic Agent: There is evidence to indicate that exposure to Olanzapine during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Oral contraceptives -- Teratogenic Agent: There is evidence to indicate that exposure to Oral contraceptives during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Osmotic diuresis: increased urination caused by the presence of certain substances in the small tubes of the kidneys.
  • Pancreatic cancer: Pancreatic cancer is a malignant neoplasm of the pancreas
  • Peganone -- Teratogenic Agent: There is evidence to indicate that exposure to Peganone (an anticonvulsant drug) during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Phenytoin toxicity: The toxic reaction of the body to the substance, possibly via allergic reaction or overdose.
  • Pheochromocytoma: Pheochromocytoma is a neuroendocrine tumor of the medulla of the adrenal glands (originating in the chromaffin cells), or extra-adrenal chromaffin tissue that failed to involute after birth and secretes excessive amounts of catecholamines, usually epinephrine and norepinephrine.
  • Possible human carcinogenic exposure -- Phenytoin: Some evidence indicates that exposure to Phenytoin (an anticonvulsant medication) has a possible link to an increased risk of developing cancer in humans. The carcinogenicity of the substance may be influenced by the duration and level of exposure.
  • Prednisolone -- Teratogenic Agent: There is evidence to indicate that exposure to Prednisolone during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Rabson-Mendenhall syndrome: A very rare genetic disorder involving severe insulin resistance which is where the body fails to be able to use insulin which is needed to control blood sugar levels.
  • Radio digito -- facial dysplasia: A very rare syndrome characterized mainly by abnormalities of the arm bones and facial anomalies.
  • Retinohepatoendocrinologic syndrome: A rare inherited disorder characterized mainly by eye, liver and endocrine function abnormalities.
  • Septicemia: A systemic inflammatory response to an infection.
  • Somatostatinoma: A very rare disorder where tumors in glands that produce somatostatin affect the secretion of the hormone. The tumor mainly occurs in the pancreas but can also occur in the intestinal tract.
  • Tacrolimus -- Teratogenic Agent: There is evidence to indicate that exposure to Tacrolimus during pregnancy may have a teratogenic effect on the fetus. A teratogen is a substance that can cause birth defects. The likelihood and severity of defects may be affected by the level of exposure and the stage of pregnancy that the exposure occurred at.
  • Thiamine responsive megaloblastic anemia syndrome: A rare genetic disorder characterized by megaloblastic anemia, hearing loss and diabetes. The condition is caused by a deficiency of a thiamine (vitamin B1) transporter protein which means that the body is unable to effectively utilize thiamine from the diet.
  • Type 1 diabetes: Severe insulin-treated diabetes typically occurring in young people.
  • Type 2 diabetes: Most common diabetes in adults, usually progressing slowly, mostly treated without insulin at diagnosis.
  • Vague symptoms: Vague, unclear, mild or non-specific symptoms
  • Vipoma: A rare disorder caused by an increase in secretion of vasoactive intestinal peptide by the pancreas. The syndrome is often caused by an islet-cell tumor (except for beta cells) in the pancreas.
  • Wolcott-Rallison syndrome: A very rare genetic condition characterized primarily by the onset of diabetes mellitus during infancy and epiphyseal dysplasia (abnormal joint development).
  • Wolfram's disease: A condition that is inherited and consists of multiple symptoms

 

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise